Paradigm Biocapital Advisors LP
- SEC CIK
- 0001855655
- Latest filing
- Aug 14, 2026
TNGX holding history
Tango Therapeutics, Inc. in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TNGX overviewAll 13F holders of TNGXFull Q2 2026 holdings
- Shares (Q2 2026)
- 6,357,523
- Value
- $198.7M
- % of portfolio
- 3.7%
- Quarters held
- 3
- Since Q3 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 6,357,523 | $198.7M | 3.7% | +2,347,844+58.6% | Added | Holders |
| Q1 2026 | 4,009,679 | $83.9M | 1.7% | +4,009,679 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −3,086,184−100.0% | Sold out | Holders |
| Q3 2025 | 3,086,184 | $25.9M | 0.8% | +3,086,184 | New | Holders |